Ovitrelle® 250mcg

Recombinant human chorionic genadotropin
Summary report on drug properties

INDICATIONS

Adult women undergoing superovulation prior to assisted reproductive techniques such as in-vitro fertilisation(IVF).Ovitrelle is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth

Anovulatory or oligoovulatory adult women:Ovitrelle is administered to trigger ovulation and luteinisation in anovulatory or oligoovulatory women after stimulation of follicular growth.